| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 8e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.32 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.35 | 2e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.29 | 0.0004 |